(PO07-10-22) Chokeberry Reduces Inflammation in Human Pre-adipocyte Cells

The ePoster content is available to NUTRITION 2022 LIVE ONLINE attendees who are logged in.<br><br>If you are registered, log in and then come back here to use this button.

Presenting Author(s)

Dale C. Brunelle, Ph.D
– ORISE Post-Doc, USDA ARS GFHNRC, Grand forks, North Dakota, United States

Co-Author(s)

NR

Nicole Redvers
– University of North Dakota
KL

Kate Larson, PhD
– Research Leader, USDA ARS, grand forks, North Dakota, United States
AB

Amy N. Bundy, B.S.
– USDA ARS, Grand Forks, North Dakota, United States
JR

James N. Roemmich, Ph.D.
– Research Physiologist/ Center Director, USDA/ARS Grand Forks Human Nutrition Research Center, Grand Forks, North Dakota, United States
DW

Donald Warne
– University of North Dakota

Disclosure(s):

Dale C. Brunelle, Ph.D: No relevant financial relationship(s) with ineligible companies to disclose.

Objectives: Chokeberry, Aronia melanocarpa, consumed as a fruit and used as a traditional food by some American Indian tribes has greater levels of anthocyanin compared to cranberries and blueberries. Animal and human studies demonstrate that chokeberry juice extract (CBE) has cardioprotective, anti-diabetic, and anti-inflammatory properties. Saturated fatty acids including palmitate (PA, 16:0) and lipopolysaccharide (LPS) produces pro-inflammatory effects by inducing inflammatory gene expression. The objective of this study was to determine the effect that CBE, Cyanidin 3-O-galactoside (C3Gal) and Cyanidin 3-glucoside(C3G) have on PA or LPS induced inflammation as measured by interleukin-6 (IL-6).

Methods: Human primary subcutaneous pre-adipocyte cells (ATCC, Manassas, Virginia) were pretreated with either 2uM C3Gal or CBE for three hours. Following pretreatment, cells were treated with 0.17mM bovine serum albumin (BSA) for control; 0.1mM PA; BSA in presence of 2uM C3Gal or CBE; and PA in presence of 2uM C3Gal or CBE. RT-qPCR analysis was conducted to determine IL-6 mRNA expression normalized to 18s rRNA expression. One-way ANOVAs were run to determine significance of group differences.

Results: Treatment of cells with PA increased (p < 0.0001) IL-6 mRNA compared to control and CBE groups. Treatment of cells with CBE decreased (p < 0.0001) PA-induced IL-6 mRNA while C3Gal did not (p=0.4657). Treatment of cells with CBE decreased (p < 0.0001) LPS-induced IL-6 mRNA while C3G treatment did not (p=0.4537).

Conclusions: PA induces inflammation, as measured by IL-6 mRNA expression, in human primary subcutaneous pre-adipocyte cells. This inflammation is reduced by treatment with CBE while isolated anthocyanin such as C3- galactoside or glucoside has partial inhibition. Future studies will identify additional chokeberry anthocyanins and flavonoids important in anti-inflammatory effects.

Funding Sources: This work was funded by grant support from the USDA Agricultural Research Service Project and NIH National Institute of General Medical Sciences, The Centers of Biomedical Research Excellence Award.